Unitedhealth Group INC Form 4 insider transactions

Director John H. Noseworthy purchased 300 shares of UnitedHealth Group (UNH) common stock at a price of $312.1563 on May 14, 2025, bringing his total direct holdings to 6,063 shares.

Director Timothy Flynn reports acquisition of 180 shares of UnitedHealth Group common stock as part of deferred compensation.

John H. Noseworthy, a director at UnitedHealth Group, acquired 180 shares of common stock as part of his quarterly compensation for board service.

Director Frederick William McNabb III acquired 183 shares of UnitedHealth Group common stock as part of his quarterly compensation for serving on the board.

Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock and deferred stock units as part of quarterly compensation.

Stephen J. Hemsley, a director at UnitedHealth Group, filed a Form 4 indicating changes in his beneficial ownership of the company's stock due to the acquisition of deferred stock units.

Director Kristen Gil reports acquiring 108 shares of UnitedHealth Group common stock as part of regular quarterly compensation.

Director Charles D. Baker reports acquisition of 168 deferred stock units of UnitedHealth Group as part of quarterly compensation.

Director Valerie Montgomery Rice acquired 180 shares of UnitedHealth Group common stock as part of her quarterly compensation for board service.

Director Michele J. Hooper reports the acquisition of 108 deferred stock units of UnitedHealth Group as part of regular quarterly compensation.

Director Kristen Gil reports acquisition of common stock and holdings in a trust related to UnitedHealth Group.

Stephen J. Hemsley, a director at UnitedHealth Group, filed a Form 4 disclosing transactions involving common stock, including acquisitions via dividend equivalents and contributions to trusts.

Director Valerie Montgomery Rice acquired 24 shares of UnitedHealth Group common stock through dividend equivalents paid on vested deferred stock units.

Director Timothy Patrick Flynn reports acquisition of 38 shares of UnitedHealth Group common stock due to dividend equivalents.

Andrew Witty, CEO of UnitedHealth Group, reports acquiring common stock through dividend equivalents paid on restricted stock units.

Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reports acquiring common stock through dividend equivalents paid on restricted stock units.

EVP & Chief Legal Officer of UnitedHealth Group, Christopher R. Zaetta, reports acquisition of common stock due to dividend equivalents and disposal of common stock.

Director Paul R. Garcia reports changes in beneficial ownership of UnitedHealth Group stock, including acquisitions through dividend equivalents and holdings in various trusts.

Chief Accounting Officer Thomas E. Roos reports acquisition of common stock due to dividend equivalents and disposal of common stock.

Director Frederick William McNabb III acquired 30 shares of UnitedHealth Group common stock through dividend equivalents on vested deferred stock units.

Timothy Noel, a UnitedHealth Group executive, reports acquiring and disposing of common stock on March 18, 2025, according to a Form 4 filing.

Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock due to dividend equivalents on restricted stock units.

John H. Noseworthy, a director at UnitedHealth Group, acquired 24 shares of common stock through dividend equivalents paid on vested deferred stock units.

Director Michele J. Hooper reports acquiring 152 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Director Charles D. Baker reports acquiring 4 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

John F. Rex, President & CFO of UnitedHealth Group, reports acquiring and disposing of common stock, including dividend equivalents, according to a Form 4 filing.

Christopher Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports acquisition and disposal of common stock and non-qualified stock options.

Chief Accounting Officer Thomas Roos reports acquisition of stock options and restricted stock units, as well as disposition of shares to cover tax obligations.

Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock and stock options.

Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reports acquisition and disposal of common stock and non-qualified stock options.